Key result
Higher aldosterone-to-renin ratio links to greater arterial stiffness in patients without suspected primary aldosteronism.
Why the study?
The clinical significance of the aldosterone-to-renin ratio when screening criteria for primary aldosteronism are not met remains largely unknown.
Cross-Sectional (n=545)
Yes
Effect estimate: β 0.146
p-value: p=<0.001
Aldosterone-to-renin ratio is directly and independently associated with large arterial stiffness in individuals without clinical suspicion of primary aldosteronism, suggesting it could serve as a clinical marker of cardiovascular risk.
ARR was associated with arterial stiffness without suspected primary aldosteronism; hypothesis-generating and should not yet change practice.
Aldosterone-to-renin ratio (ARR) is a screening tool for primary aldosteronism (PA), but the significance of ARR when the PA criteria are not met remains largely unknown. In this cross-sectional study we investigated the association of ARR with haemodynamic variables in 545 normotensive and never-medicated hypertensive subjects (267 men, 278 women, age range 19–72 years) without suspicion of PA. Supine haemodynamic data was recorded using whole-body impedance cardiography and radial tonometric pulse wave analysis. In sex-adjusted quartiles of ARR, determined as serum aldosterone to plasma renin activity ratio, the mean values were 282, 504, 744 and 1467 pmol/µg of angiotensin I/h, respectively. The only difference in haemodynamic variables between the ARR quartiles was higher pulse wave velocity (PWV) in the highest quartile versus other quartiles ( p = 0.004), while no differences in blood pressure (BP), heart rate, wave reflections, cardiac output or systemic vascular resistance were observed between the quartiles. In linear regression analysis with stepwise elimination, ARR was an independent explanatory factor for PWV (β = 0.146, p < 0.001, R 2 of the model 0.634). In conclusion, ARR was directly and independently associated with large arterial stiffness in individuals without clinical suspicion of PA. Therefore, ARR could serve as a clinical marker of cardiovascular risk. Trial registration: ClinicalTrails.gov: NCT01742702.
No takes yet. Share an insight, caveat, or question.
Kokko et al. (2020) conducted a cross-sectional in Normotension and unmedicated hypertension without primary aldosteronism (n=545). Aldosterone-to-renin ratio (ARR) was evaluated on Pulse wave velocity (PWV) (β 0.146, p=<0.001). Aldosterone-to-renin ratio was directly and independently associated with large arterial stiffness (pulse wave velocity) in individuals without clinical suspicion of primary aldosteronism (β 0.146, p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: